carnitine effect in diabetic fatty liver disease
Not Applicable
- Conditions
- non alcoholic fatty liver disease.Other specified inflammatory liver diseases
- Registration Number
- IRCT2014020316348N2
- Lead Sponsor
- Gastroentrology Recerch Center, Ahwaz Jundishapur Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Known case of diabetic type2 ? serum level of alanin aminotranspherase and aspartat aminotranspherase more than 2time of normal? and high level of triglicirid and cholestrol level ? ultrasonograghy evidences of fatty live.
Exclusion criteria: any causes of increasing liver enzymes such as viral infections? hemochromatosis ?alfa 1 anti tripsin dificiency?Wilson’s disease? autoimmune diseases? drinking (20 and 10 grams per day for men and women, respectively)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver aminotransferase. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.
- Secondary Outcome Measures
Name Time Method Serum level of triglicirid and cholestril. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.;Fasting blood glucos test. Timepoint: Before intervention and three months after initiation of the intervention. Method of measurement: Eliza.